Intuitive Surgical (NASDAQ:ISRG) EVP Sells 77 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $394.26, for a total transaction of $30,358.02. Following the completion of the transaction, the executive vice president directly owned 1,035 shares in the company, valued at $408,059.10. The trade was a 6.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.67, for a total transaction of $30,081.59.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total transaction of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $360.21, for a total value of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total value of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $414.13, for a total value of $10,353.25.
• On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $424.14, for a total value of $9,755.22.
• On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $420.12, for a total value of $9,662.76.
• On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total value of $7,916.40.

Intuitive Surgical Trading Up 1.7%

Shares of Intuitive Surgical stock traded up $6.54 during trading hours on Wednesday, hitting $397.72. 2,124,590 shares of the company were exchanged, compared to its average volume of 2,465,721. The business has a 50-day moving average of $389.89 and a 200-day moving average of $438.02. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The stock has a market capitalization of $140.51 billion, a price-to-earnings ratio of 45.56, a P/E/G ratio of 2.85 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the firm posted $1.81 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ISRG. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research report on Thursday, July 30th. Bank of America dropped their target price on Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Leerink Partners cut their target price on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Finally, Jefferies Financial Group reduced their price target on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $508.68.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $31,000. Turning Point Benefit Group Inc. grew its holdings in shares of Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 50 shares during the period. Motiv8 Investments LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $34,000. Oakworth Capital Inc. raised its holdings in Intuitive Surgical by 281.2% during the fourth quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 45 shares during the last quarter. Finally, Main Street Group LTD purchased a new stake in Intuitive Surgical during the first quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.